Had he treated those same patients with approved chemo and the same patients died, he wouldn't even have been suspected.

What's wrong with this picture?

And we all know how FDA approval is a bankable guarantee of what exatly??? Vioxx and similar were all FDA-approved.

BigPharma has a case before the fascist-packed Supreme Court that is called the "shield" law. If a person dies, is injured, maimed from an FDA-approved drug, the drug company will no longer be legally attackable, will be shielded by the law. ie, all the Vioxx,etc cases would not even appear in court.

The justification is that if 100K are helped by the drug (or does nothing for them), but 15K are directly killed by the drug, the drug company gets away free. The key point is all 115K people paid for the drug.

So, I don't see anything extreme in Dr. Simoncini's method, he has just tried to use the same treatment for cancer patients, and it is worth looking at it to see how successful he's been so far.

The fact that 3 of his patients died does not say anything alone, as far as we don't know how advanced cases they were and what caused their death. Mainstream treatment for cancer has caused thousands of deaths, but nobody talks about it. Whenever someone tries something different, he is immediately under fire and is shot to death at his first lost case.

No. Alkalizing is to AVOID being in the low end of the narrow, homeostatic range of overall body pH. ie, a cancer patient should strive to be at the alkaline end that narrow range.

When the body's pH moves out of that range, it's a pathological state.

Does alkaline diet and urine really mean cancer cells are seeing a more alkaline micro-environment? Great controversy about that.

http://www.curenaturalicancro.com/2-treatment-sodiumbicarbonate.html

A logical solution to the cancer problem, based on the arguments put forward so far, seems to stem from the world of fungi against which, at the moment, there is no useful remedy other than, in my opinion, sodium bicarbonate. The anti-fungins that are currently on the market, in fact, do not have the ability to penetrate the masses (except perhaps early administrations of azoli or of amfotercina B delivered parenterally), since they are conceived to act only at a stratified level of the epithelial type. They are therefore unable to affect mycelial aggregations that are set volumetrically and also when masked by the connectival reaction that attempts to circumscribe them.
We have seen that fungi are also able to quickly mutate their genetic structure. That means that after an initial phase of sensitivity to fungicides, in a short time they are able to codify them and to metabolize them without being damaged by them – rather, paradoxically, they extract a benefit from their high toxicity on the organism.
This happens, for example, in the prostate invasive carcinoma with congealed pelvis. There is a therapy with anti-fungins for this affliction, which at first is very effective at the symptomatological level but consistently loses its effectiveness with time.
Sodium bicarbonate, instead, as it is extremely diffusible and without that structural complexity that fungi can easily codify, retains its ability to penetrate the masses for a long time. This is also and especially due to the speed at which it disintegrates them, which makes it impossible for the fungi to adapt so that it cannot defend itself. A therapy with bicarbonate should therefore be set up using a strong dosage, continuously, and in cycles without pauses in a work of destruction which should proceed from the beginning to the end without interruption for at least 7-8 days for the first cycle, keeping in mind that a mass of 2-3-4 centimeters begins to regress consistently from the third to the fourth day, and collapses from the fourth to the fifth.
Generally speaking, the maximum limit of the dosage that can be administered in a session gravitates around 500 cm3 of sodium bicarbonate at five per cent solution, with the possibility of increasing or decreasing the dosage by 20 per cent as a function of the body mass of the individual to be treated and in the presence of multiple localizations upon which to apportion a greater quantity of salts.
We must underline that the dosages indicated, as they are harmless, are the very same that have already been utilized without any problem for more than 30 years in a myriad of other morbid situations such as:
• Severe diabetic ketoacidosis
• Cardio-respiratory reanimation
• Pregnancy
• Hemodialysis
• Peritoneal dialysis
• Pharmacological toxicosis
• Hepatopathy
• Vascular surgery

http://www.curenaturalicancro.com/safety-sodium-bicarbonate.html

Doses of sodium bicarbonate at 5%, as indicated in the Simoncini treatment are innocuous. In fact they have been used without any problems for over 30 years in a multitude of other deseases such as:
• Severe diabetic ketoacidosis (1)
• Cardiopulmonary resuscitation (2)
• Pregnancy (3)
• Hemodialysis (4)
• Peritoneal dialysis. (5)
• Pharmacological toxicosis. (6)
• Hepatopathy. (7)
• Vascular surgery operations (8)
1. Gamba, G., “Bicarbonate therapy in severe diabetic ketoacidosis. A double blind, randomized, placebo controlled trial.” (Rev Invest Clin 1991 Jul-Sep;43(3):234-8). Miyares Gomez A. in “Diabetic ketoacidosis in childhood: the first day of treatment (An Esp Pediatr 1989 Apr;30(4):279-83).
2. Levy, M.M., “An evidence-based evaluation of the use of sodium bicarbonate during cardiopulmonary resuscitation” (Crit Care Clin 1998 Jul;14(3):457-83). Vukmir, R.B., Sodium bicarbonate in cardiac arrest: a reappraisal (Am J Emerg Med 1996 Mar;14(2):192-206). Bar-Joseph, G., “Clinical use of sodium bicarbonate during cardiopulmonary resuscitation--is it used sensibly?” (Resuscitation 2002 Jul;54(1):47-55).
3. Zhang. L.,“Perhydrit and sodium bicarbonate improve maternal gases and acid-base status during the second stage of labor” Department of Obstetrics and Gynecology, Xiangya Hospital, Hunan Medical University, Changsha 410008. Maeda, Y., “Perioperative administration of bicarbonated solution to a patient with mitochondrial encephalomyopathy” (Masui 2001 Mar;50(3):299-303).
4. Avdic. E., “Bicarbonate versus acetate hemodialysis: effects on the acid-base status” (Med Arh 2001;55(4):231-3).
5. Feriani, M., “Randomized long-term evaluation of bicarbonate-buffered CAPD solution.” (Kidney Int 1998 Nov;54(5):1731-8).
6. Vrijlandt, P.J., “Sodium bicarbonate infusion for intoxication with tricyclic antidepressives: recommended inspite of lack of scientific evidence” Ned Tijdschr Geneeskd 2001 Sep 1;145(35):1686-9). Knudsen, K., “Epinephrine and sodium bicarbonate independently and additively increase survival in experimental amitriptyline poisoning.” (Crit Care Med 1997 Apr;25(4):669-74).
7. Silomon, M., “Effect of sodium bicarbonate infusion on hepatocyte Ca2+ overload during resuscitation from hemorrhagic shock.” (Resuscitation 1998 Apr;37(1):27-32). Mariano, F., “Insufficient correction of blood bicarbonate levels in biguanide lactic acidosis treated with CVVH and bicarbonate replacement fluids” (Minerva Urol Nefrol 1997 Sep;49(3):133-6).
8. Dement'eva, I.I., “Calculation of the dose of sodium bicarbonate in the treatment of metabolic acidosis in surgery with and deep hypothermic circulatory arrest” (Anesteziol Reanimatol 1997 Sep-Oct;(5):42-4).

more chemical information about sodium bicarbonate (pdf)

back to the index